{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:31:05Z","timestamp":1793633465025,"version":"4.5.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2021\/06769-0"],"award-info":[{"award-number":["2021\/06769-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003827","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["2022-2.1.1-NL-2022-00008"],"award-info":[{"award-number":["2022-2.1.1-NL-2022-00008"]}],"id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003827","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["2021-1.1.4-GYORS\\u00CDT\\u00D3S\\u00C1V-2022-00008"],"award-info":[{"award-number":["2021-1.1.4-GYORS\\u00CDT\\u00D3S\\u00C1V-2022-00008"]}],"id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003825","name":"Hungarian Academy of Sciences","doi-asserted-by":"publisher","award":["LP2017-7\/2017"],"award-info":[{"award-number":["LP2017-7\/2017"]}],"id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.omtn.2026.103083","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:11:37Z","timestamp":1788390697000},"page":"103083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["An mRNA-lipid nanoparticle vaccine targeting the Plasmodium vivax E140 antigen"],"prefix":"10.1016","volume":"37","author":[{"given":"Rodolfo Ferreira","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Antonio de","family":"Souza-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor","family":"Antunes da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"S\u00e1rk\u00f6zy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1t\u00e9","family":"Vadovics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edit","family":"\u00c1brah\u00e1m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Bioni","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Beatriz","family":"Boscardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel H.J.","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Caroline Campos","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Lipinszki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2564-3742","authenticated-orcid":false,"given":"Daniel Youssef","family":"Bargieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.103083_bib1","series-title":"World Malaria Report 2024","year":"2024"},{"key":"10.1016\/j.omtn.2026.103083_bib2","first-page":"1","article-title":"Updates on Malaria Epidemiology and Prevention Strategies","author":"Gonz\u00e1lez-Sanz","year":"2023","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.omtn.2026.103083_bib3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrmicro.2017.161","article-title":"Drug resistance in Plasmodium","volume":"16","author":"Haldar","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.omtn.2026.103083_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12936-023-04444-2","article-title":"Impact of insecticide resistance on malaria vector competence: a literature review","volume":"22","author":"Suh","year":"2023","journal-title":"Malar. J."},{"key":"10.1016\/j.omtn.2026.103083_bib5","article-title":"Plasmodium vivax vaccine: What is the best way to go?","volume":"13","author":"da Veiga","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2026.103083_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1797","article-title":"Unlocking the potential of novel RTS, S\/AS01, and R21\/Matrix-M malaria vaccines in African nations","volume":"7","author":"Oduoye","year":"2024","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.omtn.2026.103083_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/14760584.2021.1880898","article-title":"Progress towards the development of a P. vivax vaccine","volume":"20","author":"De","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.omtn.2026.103083_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2021.102525","article-title":"Plasmodium vivax transmission-blocking vaccines: Progress, challenges and innovation","volume":"87","author":"Tachibana","year":"2022","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.omtn.2026.103083_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232234","article-title":"Novel malaria antigen Plasmodium yoelii E140 induces antibody-mediated sterile protection in mice against malaria challenge","volume":"15","author":"Smith","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2026.103083_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw2619","article-title":"The Malaria Cell Atlas: Single parasite transcriptomes across the complete Plasmodium life cycle","volume":"365","author":"Howick","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103083_bib11","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","article-title":"mRNA vaccines for infectious diseases - advances, challenges and opportunities","volume":"23","author":"Pardi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2026.103083_bib12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cell.2016.07.055","article-title":"Malaria: Biology and Disease","volume":"167","author":"Cowman","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103083_bib13","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025585","article-title":"The Biology of Plasmodium vivax","volume":"7","author":"Adams","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.omtn.2026.103083_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102645","article-title":"mRNA-LNP vaccine encoding the Plasmodium vivax circumsporozoite protein is highly immunogenic and confers protection in mice","volume":"36","author":"Limsalakpetch","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.103083_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41541-023-00786-9","article-title":"A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax","volume":"8","author":"Kunkeaw","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.omtn.2026.103083_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000195","article-title":"Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivity","volume":"4","author":"Lasonder","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2026.103083_bib17","first-page":"361","article-title":"IgG1 and IgG2a profile of serum antibodies to Leishmania major amastigote in BALB\/c and C57BL\/6Mice","volume":"12","author":"Ebrahimpoor","year":"2013","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"10.1016\/j.omtn.2026.103083_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.lfs.2018.05.056","article-title":"Mouse strain and sex as determinants of immune response to trivalent influenza vaccine","volume":"207","author":"Petrovi\u0107","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.omtn.2026.103083_bib19","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1128\/IAI.70.5.2319-2325.2002","article-title":"Nonviable Burkholderia mallei induces a mixed Th1- and Th2-like cytokine response in BALB\/c mice","volume":"70","author":"Amemiya","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.omtn.2026.103083_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12866-018-1186-8","article-title":"Comparative analysis of humoral immune responses and pathologies of BALB\/c and C57BL\/6 wildtype mice experimentally infected with a highly virulent Rodentibacter pneumotropicus (Pasteurella pneumotropica) strain","volume":"18","author":"Fornefett","year":"2018","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.omtn.2026.103083_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-3024.1995.tb00880.x","article-title":"Interferon-gamma and the induction of protective IgG2a antibodies in non-lethal Plasmodium berghei infections of mice","volume":"17","author":"Waki","year":"1995","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.omtn.2026.103083_bib22","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1128\/iai.59.10.3547-3554.1991","article-title":"Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii","volume":"59","author":"White","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.omtn.2026.103083_bib23","article-title":"IgG Subclass Switch in Volunteers Repeatedly Immunized with the Full-Length Plasmodium falciparum Merozoite Surface Protein 1 (MSP1)","volume":"12","author":"Rathay","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.omtn.2026.103083_bib24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41541-021-00372-x","article-title":"Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infection","volume":"6","author":"Seaton","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.omtn.2026.103083_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12916-018-1186-4","article-title":"Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S\/AS01E vaccination in African children","volume":"16","author":"Ubillos","year":"2018","journal-title":"BMC Med."},{"key":"10.1016\/j.omtn.2026.103083_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.0141-9838.2001.00440.x","article-title":"Naturally acquired immunoglobulin (Ig)G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2","volume":"24","author":"Ndungu","year":"2002","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.omtn.2026.103083_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040320","article-title":"Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3","volume":"4","author":"Roussilhon","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.omtn.2026.103083_bib28","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/infdis\/jiy258","article-title":"Cytophilic Antibodies Against Key Plasmodium falciparum Blood Stage Antigens Contribute to Protection Against Clinical Malaria in a High Transmission Region of Eastern India","volume":"218","author":"Kana","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.omtn.2026.103083_bib29","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1038\/s41467-025-58963-4","article-title":"Recent perspectives in clinical development of malaria vaccines","volume":"16","author":"Feehan","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103083_bib30","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nature05361","article-title":"The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites","volume":"444","author":"Kumar","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103083_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax4489","article-title":"IgM in human immunity to Plasmodium falciparum malaria","volume":"5","author":"Boyle","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2026.103083_bib32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41541-023-00701-2","article-title":"Multifunctional IgG\/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine","volume":"8","author":"Rosenkranz","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.omtn.2026.103083_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-021-03738-2","article-title":"SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses","volume":"596","author":"Turner","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103083_bib34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-022-04527-1","article-title":"Germinal centre-driven maturation of B cell response to mRNA vaccination","volume":"604","author":"Kim","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103083_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abm8389","article-title":"Long-lived plasma cells accumulate in the bone marrow at a constant rate from early in an immune response","volume":"7","author":"Robinson","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.omtn.2026.103083_bib36","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.omtn.2026.103083_bib37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41591-024-03278-y","article-title":"SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccination","volume":"31","author":"Nguyen","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2026.103083_bib38","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.hlife.2024.09.002","article-title":"Comparison of antigen-specific B cell responses reveals disparity in immunogenicity and memory B cell formation across COVID-19 vaccine platforms","volume":"2","author":"Guo","year":"2024","journal-title":"hLife"},{"key":"10.1016\/j.omtn.2026.103083_bib39","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20171450","article-title":"Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses","volume":"215","author":"Pardi","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omtn.2026.103083_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040337","article-title":"Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein","volume":"4","author":"Grimberg","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.omtn.2026.103083_bib41","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.4049\/jimmunol.1801631","article-title":"Identification and Characterization of Functional Human Monoclonal Antibodies to Plasmodium vivax Duffy-Binding Protein","volume":"202","author":"Carias","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtn.2026.103083_bib42","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/s41467-021-21811-2","article-title":"Naturally acquired blocking human monoclonal antibodies to Plasmodium vivax reticulocyte binding protein 2b","volume":"12","author":"Chan","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103083_bib43","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1128\/IAI.00157-16","article-title":"Chemically Attenuated Blood-Stage Plasmodium yoelii Parasites Induce Long-Lived and Strain-Transcending Protection","volume":"84","author":"Raja","year":"2016","journal-title":"Infect. Immun."},{"key":"10.1016\/j.omtn.2026.103083_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02657-21","article-title":"Development and Evaluation of a Cryopreserved Whole-Parasite Vaccine in a Rodent Model of Blood-Stage Malaria","volume":"12","author":"Stanisic","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.omtn.2026.103083_bib45","doi-asserted-by":"crossref","first-page":"9129","DOI":"10.1038\/s41598-017-09684-2","article-title":"Immunological memory to blood-stage malaria infection is controlled by the histamine releasing factor (HRF) of the parasite","volume":"7","author":"Demarta-Gatsi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.103083_bib46","doi-asserted-by":"crossref","first-page":"12045","DOI":"10.1073\/pnas.1702944114","article-title":"Synergistic malaria vaccine combinations identified by systematic antigen screening","volume":"114","author":"Bustamante","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.103083_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15956-3","article-title":"A multi-epitope vaccine designed against blood-stage of malaria: an immunoinformatic and structural approach","volume":"12","author":"Atapour","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.103083_bib48","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.vaccine.2014.03.020","article-title":"A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages","volume":"32","author":"Theisen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2026.103083_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42014","article-title":"Computational design, expression, and characterization of a Plasmodium falciparum multi-epitope, multi-stage vaccine candidate (PfCTMAG)","volume":"11","author":"Chick","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.omtn.2026.103083_bib50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-1-0716-3770-8_7","article-title":"Production and Evaluation of Nucleoside-Modified mRNA Vaccines for Infectious Diseases","volume":"2786","author":"Vadovics","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2026.103083_bib51","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","article-title":"A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA","volume":"15","author":"Baiersd\u00f6rfer","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.103083_bib52","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/2211-5463.13939","article-title":"Expression and purification of E140 protein antigen fragments of Plasmodium vivax and Plasmodium berghei for serological assays","volume":"15","author":"Marques","year":"2025","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.omtn.2026.103083_bib53","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1021\/acssynbio.8b00332","article-title":"Enhancing the Translational Capacity of E. coli by Resolving the Codon Bias","volume":"7","author":"Lipinszki","year":"2018","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.omtn.2026.103083_bib54","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.ymthe.2023.07.022","article-title":"Development of an mRNA-lipid nanoparticle vaccine against Lyme disease","volume":"31","author":"Pine","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.103083_bib55","article-title":"TriMap: Large-scale Dimensionality Reduction Using Triplets","author":"Amid","year":"2022","journal-title":"arXiv"},{"key":"10.1016\/j.omtn.2026.103083_bib56","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fimmu.2020.00028","article-title":"Protective Immunity in Mice Immunized With P. vivax MSP1(19)-Based Formulations and Challenged With P. berghei Expressing PvMSP1(19)","volume":"11","author":"Dobrescu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2026.103083_bib57","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1038\/s41467-022-32149-8","article-title":"Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses","volume":"13","author":"Pardi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103083_bib58","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1475-2875-8-115","article-title":"Effective and cheap removal of leukocytes and platelets from Plasmodium vivax infected blood","volume":"8","author":"Sriprawat","year":"2009","journal-title":"Malar. J."},{"key":"10.1016\/j.omtn.2026.103083_bib59","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/AAC.47.1.170-173.2003","article-title":"Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic","volume":"47","author":"Russell","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.omtn.2026.103083_bib60","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2011-04-348748","article-title":"A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax","volume":"118","author":"Russell","year":"2011","journal-title":"Blood"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126002544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126002544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:14:25Z","timestamp":1793632465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126002544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2162253126002544"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103083","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An mRNA-lipid nanoparticle vaccine targeting the Plasmodium vivax E140 antigen","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"103083"}}